STOCK TITAN

Cronos Group (CRON) officer reports 6,423 RSUs settled into common stock

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Cronos Group Inc. executive Arye Weigensberg, Senior Vice President and Head of Research and Development, reported the vesting and settlement of 6,423 restricted stock units into common shares on 12/13/2025 at an exercise price of $0 per share.

After this transaction, he directly owns 135,892 Cronos Group common shares and continues to hold 153,918 restricted stock units, each representing a contingent right to receive one common share. These RSUs were originally granted on December 13, 2022 as part of a 19,266-unit award vesting in three substantially equal annual installments.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Weigensberg Arye

(Last) (First) (Middle)
4491 CONCESSION RD 12

(Street)
STAYNER A6 L0M 1S0

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Cronos Group Inc. [ CRON ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
See Remarks
3. Date of Earliest Transaction (Month/Day/Year)
12/13/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
COMMON SHARES 12/13/2025 M 6,423 A $0(1) 135,892 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
RESTRICTED STOCK UNITS (1) 12/13/2025 M 6,423 (2) (2) COMMON SHARES 6,423 $0 153,918 D
Explanation of Responses:
1. Each restricted stock unit ("RSU") represents a contingent right to receive one common share of Cronos Group Inc.
2. On December 13, 2022, the reporting person was granted 19,266 RSUs, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.
Remarks:
Senior Vice President, Head of Research and Development
/s/ Aaron B. Werner, as attorney-in-fact for Arye Weigensberg 12/16/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider stock transaction did Cronos Group (CRON) report in this filing?

The filing reports that executive Arye Weigensberg settled 6,423 restricted stock units (RSUs) into Cronos Group common shares on 12/13/2025 at a price of $0 per share.

How many Cronos Group (CRON) common shares does the executive own after this transaction?

Following the reported transaction, the executive is shown as directly owning 135,892 Cronos Group common shares.

How many restricted stock units does the Cronos Group (CRON) executive still hold?

After the vesting of 6,423 RSUs into common shares, the Form 4 shows the executive beneficially owning 153,918 restricted stock units as derivative securities.

What are the terms of the restricted stock units reported for Cronos Group (CRON)?

The explanation states that each restricted stock unit (RSU) represents a contingent right to receive one common share of Cronos Group Inc.

When were the Cronos Group (CRON) RSUs originally granted and how do they vest?

On December 13, 2022, the reporting person was granted 19,266 RSUs, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.

Did the Cronos Group (CRON) executive pay cash to receive the 6,423 common shares?

No cash price is indicated for the share delivery; the transaction table lists a price of $0 in connection with the 6,423 common shares received upon RSU settlement.

Cronos Group

NASDAQ:CRON

CRON Rankings

CRON Latest News

CRON Latest SEC Filings

CRON Stock Data

1.16B
197.78M
47.07%
14.7%
0.68%
Drug Manufacturers - Specialty & Generic
Medicinal Chemicals & Botanical Products
Link
Canada
STAYNER